Related Experiment Video
Updated: Sep 8, 2025
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Assessing the Impact of the Low-FODMAP Diet on IBS Management in Asian Countries: A Systematic Review and
Riya Khurana1, Gurseen Rakhra2
1Department of Nutrition and Dietetics, School of Allied Health Sciences, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, 121004, India.
Background:
Irritable bowel syndrome (IBS) is a multifactorial disease which is believed to have a complex pathogenesis unknown till date. IBS is considered chronic condition that can lower the quality of life of a patient. Diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is considered to be a potential therapeutic treatment to improve the symptoms of IBS.
Methodology:
A systematic literature search and meta-analysis was conducted to explore the effect of low-FODMAP diet in IBS patients of Asia. The search was conducted through PubMed, Cochrane library, Embase, and Google Scholar.
Results:
The literature search after careful screening yielded 291 results. Out of these, only 6 were included for the meta- analysis. Post-intervention scores for symptom severity was notably lower in group following low-FODMAP diet.
Conclusion:
The meta-analysis provided us with the evidence with an improvement in symptom severity of patients who followed low-FODMAP diet as compared to those who followed traditional or general dietary advice. The study also emphasized on the need for more rigorous and long-term trials for low-FODMAP diet in Asia to determine its efficacy on a larger scale.
More Related Videos
Related Concept Videos
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: